33 AGE harnesses epigenetics, metabolomics, and AI-driven intervention design to reverse biological aging — measurably, safely, and at scale.
Scientific literature identifies age 33 as a critical inflection point where cumulative molecular damage begins outpacing repair mechanisms. We intervene precisely at this threshold — and beyond — to reprogram the aging trajectory.
Our platform integrates four layers of biological data to create a complete picture of your aging process — then acts on it.
Using next-generation DNA methylation sequencing, we measure your biological age with clinical precision. Our proprietary clock algorithm correlates with 847 CpG sites — 3x more than standard panels — delivering the most accurate age assessment commercially available.
We analyze 3,200+ proteins and metabolites to identify the specific pathways driving your aging. Inflammation, glycation, oxidative stress, mitochondrial decline — each mapped and quantified for targeted intervention.
Our machine learning models process your multi-omic data against 200,000+ longitudinal records to generate hyper-personalized protocols. Every recommendation is evidence-ranked and continuously refined based on your response data.
Monthly micro-assessments and quarterly deep panels create a real-time feedback loop. Your protocol adapts dynamically — amplifying what works, adjusting what doesn't, ensuring continuous biological age improvement.
Each program is designed around specific biological targets, with clear metrics and timelines.
Comprehensive biological age assessment and personalized roadmap generation.
Reset metabolic flexibility and mitochondrial efficiency through targeted interventions.
Target senescent cells and restore NAD+ levels to reverse age-related cellular decline.
Protect and restore cognitive function through brain-specific longevity science.
Precision hormonal optimization addressing age-related endocrine decline.
Concierge-level longevity management for maximum healthspan ROI.
A decade of relentless focus on one question: can we make aging optional?
Expanded to 15 countries with clinical centers in Singapore, Tokyo, London, Dubai, and San Francisco. 47,000+ active members achieving measurable biological age reversal through our AI-driven protocols.
Launched our proprietary longevity AI trained on 200,000+ longitudinal multi-omic records. Demonstrated 3x improvement in protocol efficacy versus standardized approaches in a controlled 12-month study.
Published landmark results in peer-reviewed journals showing statistically significant biological age reduction (mean: 6.4 years) across 4,200 participants over 18 months of intervention.
Launched the 33 AGE digital health platform integrating continuous biomarker tracking, AI-generated protocols, and remote physician oversight — making precision longevity accessible beyond clinical settings.
33 AGE PTE. LTD. established in Singapore by a team of aging researchers, computational biologists, and preventive medicine physicians united by a shared conviction: aging is not inevitable.